Immunology and Cell Biology

FIGURES AND TABLES

FROM:

The evolution of clinical immunology and allergy in Australia

Antony Basten

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Figure 1.

Exponential rise in monoclonal antibodies (mAbs) approved for clinical use. Now 50% of new drug approvals are for mAbs or equivalent fusion proteins.

Full figure and legend (41K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Figure 2.

The vicious cycle: outcomes of potential advances in vaccinology in the developing world.

Full figure and legend (116K)
Table 1 - SWOT analysis - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 1 - SWOT analysis.

Full table
Table 2 - Crystal-ball gazing and future priorities in clinical immunology//allergy19 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 2 - Crystal-ball gazing and future priorities in clinical immunology/allergy19 .

Full table
Table 3 - Framework for immunotherapy - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 3 - Framework for immunotherapy.

Full table
BACK TO ARTICLE